-
1
-
-
84865445563
-
Lack of information and access to advanced treatment for Parkinson's disease patients
-
Lökk J. Lack of information and access to advanced treatment for Parkinson's disease patients. J Multidisciplinary Healthc 2011;4:433-9.
-
(2011)
J Multidisciplinary Healthc
, vol.4
, pp. 433-439
-
-
Lökk, J.1
-
2
-
-
0035353725
-
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
-
Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 2001;16:448-58.
-
(2001)
Mov Disord
, vol.16
, pp. 448-458
-
-
Ahlskog, J.E.1
Muenter, M.D.2
-
3
-
-
79957652863
-
The treatment of early Parkinson's disease: Levodopa rehabilitated
-
Vlaar A, Hovestadt A, van Laar T, et al. The treatment of early Parkinson's disease: levodopa rehabilitated. Pract Neurol 2011;11:145-52.
-
(2011)
Pract Neurol
, vol.11
, pp. 145-152
-
-
Vlaar, A.1
Hovestadt, A.2
van Laar, T.3
-
4
-
-
41449108899
-
The sensitivity and specificity of the 9-item Wearing-off Questionnaire
-
Stacy M A, Murphy JM, Greeley DR, et al. The sensitivity and specificity of the 9-item Wearing-off Questionnaire. Parkinsonism Relat Disord 2008;14:205-12.
-
(2008)
Parkinsonism Relat Disord
, vol.14
, pp. 205-212
-
-
Stacy, M.A.1
Murphy, J.M.2
Greeley, D.R.3
-
5
-
-
58149133708
-
The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
-
Stocchi F. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 1):S9-15.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, Issue.SUPPL. 1
-
-
Stocchi, F.1
-
7
-
-
84870057900
-
Impulse control and related disorders in Parkinson's disease
-
Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson's disease. Neurodegener Dis 2013;11:63-71.
-
(2013)
Neurodegener Dis
, vol.11
, pp. 63-71
-
-
Weintraub, D.1
Nirenberg, M.J.2
-
8
-
-
77953206789
-
Surgical management of Parkinson's disease
-
Foltynie T, Hariz MI. Surgical management of Parkinson's disease. Expert Rev Neurother 2010;10:903-14.
-
(2010)
Expert Rev Neurother
, vol.10
, pp. 903-914
-
-
Foltynie, T.1
Hariz, M.I.2
-
9
-
-
0025169590
-
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
-
Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
-
(1990)
Science
, vol.249
, pp. 1436-1438
-
-
Bergman, H.1
Wichmann, T.2
Delong, M.R.3
-
10
-
-
0022474704
-
Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: Preliminary observations
-
Kurlan R, Rubin AJ, Miller C, et al. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 1986;20:262-5.
-
(1986)
Ann Neurol
, vol.20
, pp. 262-265
-
-
Kurlan, R.1
Rubin, A.J.2
Miller, C.3
-
11
-
-
33750725397
-
Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease
-
Nyholm D. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Expert Rev Neurother 2006;6:1403-11.
-
(2006)
Expert Rev Neurother
, vol.6
, pp. 1403-1411
-
-
Nyholm, D.1
-
12
-
-
70450230345
-
Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease
-
Clarke CE, Worth P, Grosset D, et al. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord 2009;15:728-41.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, pp. 728-741
-
-
Clarke, C.E.1
Worth, P.2
Grosset, D.3
-
13
-
-
52649108045
-
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
-
Ruiz PJ García, Ignacio A Sesar, Pensado B Ares, et al. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study. Mov Disord 2008;23:1130-6.
-
(2008)
Mov Disord
, vol.23
, pp. 1130-1136
-
-
García, R.P.J.1
Sesar, I.A.2
Ares, P.B.3
-
14
-
-
20144366287
-
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges
-
Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Mov Disord 2005;20:151-7.
-
(2005)
Mov Disord
, vol.20
, pp. 151-157
-
-
Katzenschlager, R.1
Hughes, A.2
Evans, A.3
-
15
-
-
58149385649
-
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial
-
Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
-
(2009)
JAMA
, vol.301
, pp. 63-73
-
-
Weaver, F.M.1
Follett, K.2
Stern, M.3
-
16
-
-
33748139412
-
A randomized trial of deep-brain stimulation for Parkinson's disease
-
Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
-
(2006)
N Engl J Med
, vol.355
, pp. 896-908
-
-
Deuschl, G.1
Schade-Brittinger, C.2
Krack, P.3
-
17
-
-
77952320903
-
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): A randomised, open-label trial
-
Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-91.
-
(2010)
Lancet Neurol
, vol.9
, pp. 581-591
-
-
Williams, A.1
Gill, S.2
Varma, T.3
-
18
-
-
2542571133
-
Long-term results of bilateral pallidal stimulation in Parkinson's disease
-
Volkmann J, Allert N, Voges J, et al. Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 2004;55:871-5.
-
(2004)
Ann Neurol
, vol.55
, pp. 871-875
-
-
Volkmann, J.1
Allert, N.2
Voges, J.3
-
19
-
-
77953169733
-
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease
-
Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-91.
-
(2010)
N Engl J Med
, vol.362
, pp. 2077-2091
-
-
Follett, K.A.1
Weaver, F.M.2
Stern, M.3
-
20
-
-
0242658923
-
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease
-
Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349:1925-34.
-
(2003)
N Engl J Med
, vol.349
, pp. 1925-1934
-
-
Krack, P.1
Batir, A.2
van Blercom, N.3
-
21
-
-
38049079782
-
Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease
-
Valldeoriola F, Morsi O, Tolosa E, et al. Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease. Mov Disord 2007;22:2183-91.
-
(2007)
Mov Disord
, vol.22
, pp. 2183-2191
-
-
Valldeoriola, F.1
Morsi, O.2
Tolosa, E.3
-
22
-
-
84871364493
-
Randomised, double-blind, double dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety
-
Olanow CW, Antonini A, Kieburtz K, et al. Randomised, double-blind, double dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy and safety. Mov Disord 2012;27: S131-2.
-
(2012)
Mov Disord
, vol.27
-
-
Olanow, C.W.1
Antonini, A.2
Kieburtz, K.3
-
23
-
-
80052729549
-
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK
-
Lowin J, Bergman A, Chaudhuri KR, et al. A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK. J Med Econ 2011;14:584-93.
-
(2011)
J Med Econ
, vol.14
, pp. 584-593
-
-
Lowin, J.1
Bergman, A.2
Chaudhuri, K.R.3
-
25
-
-
84877646050
-
Cost analysis of the treatments for patients with advanced Parkinson's disease
-
Valldeoriola F, Puig-Junoy J, Puig-Peiró R. Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study. J Med Econ 2013;16:191-201.
-
(2013)
SCOPE Study. J Med Econ
, vol.16
, pp. 191-201
-
-
Valldeoriola, F.1
Puig-Junoy, J.2
Puig-Peiró, R.3
-
26
-
-
73049100901
-
Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease
-
Antonini A, Odin P. Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson's disease. Parkinsonism Relat Disord 2009;15(Suppl 4):S97-100.
-
(2009)
Parkinsonism Relat Disord
, vol.15
, Issue.SUPPL. 4
-
-
Antonini, A.1
Odin, P.2
-
27
-
-
58149393691
-
Apomorphine nodules in Parkinson's disease: Best practice considerations
-
Todd A, James C-A. Apomorphine nodules in Parkinson's disease: best practice considerations. Br J Community Nurs 2008;13:457-63.
-
(2008)
Br J Community Nurs
, vol.13
, pp. 457-463
-
-
Todd, A.1
James, C.-A.2
-
28
-
-
33745854279
-
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
-
Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 1):S290-304.
-
(2006)
Mov Disord
, vol.21
, Issue.SUPPL. 1
-
-
Kleiner-Fisman, G.1
Herzog, J.2
Fisman, D.N.3
-
29
-
-
77955803941
-
Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy
-
Urban PP, Wellach I, Faiss S, et al. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010;25: 1748-52.
-
(2010)
Mov Disord
, vol.25
, pp. 1748-1752
-
-
Urban, P.P.1
Wellach, I.2
Faiss, S.3
-
30
-
-
34247547815
-
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
-
Derost P-P, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007;68:1345-55.
-
(2007)
Neurology
, vol.68
, pp. 1345-1355
-
-
Derost, P.-P.1
Ouchchane, L.2
Morand, D.3
-
31
-
-
0031765885
-
Subcutaneous apomorphine in late stage Parkinson's disease: A long term follow up
-
Pietz K, Hagell P, Odin P. Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry 1998;65:709-16.
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.65
, pp. 709-716
-
-
Pietz, K.1
Hagell, P.2
Odin, P.3
-
32
-
-
79959367266
-
Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: A review
-
Broen M, Duits A, Visser-Vandewalle V, et al. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord 2011;17:413-17.
-
(2011)
Parkinsonism Relat Disord
, vol.17
, pp. 413-417
-
-
Broen, M.1
Duits, A.2
Visser-Vandewalle, V.3
-
33
-
-
84858629248
-
Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: Which target?
-
Follett KA, Torres-Russotto D. Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target? Parkinsonism Relat Disord 2012;18(Suppl 1): S165-7.
-
(2012)
Parkinsonism Relat Disord
, vol.18
, Issue.SUPPL. 1
-
-
Follett, K.A.1
Torres-Russotto, D.2
|